Investment Q&A

Q: Thank you for your prompt answer; I was not sure whether the company consistently advised much lower prospects or whether there was some seasonality to their earnings. My take is that corporate earnings prospects do need to be as accurate as possible and is an appropriate response, and guidance, to shareholders investment.

Q: Can you comment on earnings and prospects please

Q: Earnings are up but outlook is down - possibly because of Kennedy appointment - would appreciate your comment as I do not seem able to access their earnings statement recording.

Q: Your thoughts on the most recent results for MCK would be appreciated. Thanks
Ian

Q: Hello, can you please provide your opinion of IXJ and whether you think it is a buy at its current price.

Also, if there is a different US healthcare ETF that you think is better please provide advise why and what you think a good entry price is.

Thanks as always for the advice.
Paula

Q: Hi 5i,

Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.

Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?

If so, what would be the longer term implications for the company?

Thanks.

Q: Would welcome your analysis on this small cap- it has recently received some positive reports. It appears to be cash flow positive and has a new drug approval.

Q: I know this is a small cap but it took a big haircut today. Were the results that bad or is it a result of being thinly traded? Thanks as always.

Q: Hi 5I
I own VMD and up nicely, but thinking of switching to VHI for better growth. Could I get your thoughts on this move.

Q: Does the recent price decline represent a buying opportunity?

Q: Your thoughts on Merck this morning please,do you see any upside?I hold it in my rif and am still showing a small profit.Buy,hold or sell?

Q: Can you please give me your input on PFE earnings. They beat the earnings however stock is down,

Thanks for your great service

Q: Can you provide your thoughts on this weeks KKR investment in HSIC. What does this mean for HSIC and its possible future.

Q: Gern has been trending down since its spike up after getting FDA approval. Is this a typical quiet period for a biotech before revenues begin? Can I get your perspective on Gern, please.

Q: Any idea why Well has dropped so much in the last few weeks and especially today?

Q: One of my children (early 20's) has funds in a TFSA they are looking to put in a high risk/high return stock. I'd asked them to do some homework on their own and they've (with some back and forth) come up with 3 names; 2 of which do not register when symbols entered.

Already owned are ASCU (1/2 position), Full positions of BN, LMN, RY, TCS, 1.5x positions of TVE, GOOG and 3x position of NVDA.

Biotech or tech seem to be the preferred themes but are not "must own" if there is something better,

The top 3 names so far are Coveo, Cardiol and Oncolytics Biotech. I would appreciate your thoughts on these 3 options, perhaps place them in order of preference and add 2 you would recommend as a high risk/high reward test.

Great work all....thank you.

Q: Tempus AI Inc. (TEM:US).

Your opinion to buy or not?

Thank you.

Q: Hi 5i, I was curious on your ranking of SIS being highly impacted by tarrifs. I was of the view that FDA approved items would be exempt. Please comment.

Thx.

Q: Thoughts on today’s announcement?

Q: Cosciens seems to be in a death spiral since the merger. Is there any hope here?